Profiel
David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
He is an Independent Director at Abliva AB since 2017.
He is also a Director at Amylonix AB and Disruptive Pharma Holding AB. Formerly, Mr. Bejker was Chief Executive Officer & Director at Affibody AB from 2003 to 2005.
Other former roles include Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduate studies at Stockholm School of Economics.
Actieve functies van David Bejker
| Bedrijven | Functie | Begin |
|---|---|---|
| ABLIVA AB | Directeur/Bestuurslid | 27-04-2017 |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Algemeen Directeur | 01-12-2018 |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Directeur/Bestuurslid | - |
Disruptive Pharma Holding AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van David Bejker
| Bedrijven | Functie | Einde |
|---|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Algemeen Directeur | 01-07-2005 |
| LIDDS AB | Directeur/Bestuurslid | - |
| NEXSTIM PLC | Corporate Officer/Principal | - |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Opleiding van David Bejker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Abliva AB
Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexstim Oyj
Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
LIDDS AB
LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Amylonix AB
Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area | Health Technology |
Disruptive Pharma Holding AB |
















